NEW YORK, May 6, 2013 /PRNewswire/ -- Today Highline Research Advisors initiated coverage through Empire Asset Management Company, a FINRA member (143007) of Trovagene (NASDAQ:TROV) with a BUY rating and 12 month price target of $17.00SOURCE Empire Asset Management Company
Highline Research Advisors Initiates Coverage On Trovagene (NASDAQ:TROV) With A Buy Rating.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts